Results 161 to 170 of about 388,394 (322)

Psychiatric comorbidity and the long-term care of people with aids [PDF]

open access: green, 2000
Joseph L. Goulet   +4 more
openalex   +1 more source

Comparison of Clinical Scores for Predicting Stroke‐Associated Pneumonia After Acute Ischemic Stroke

open access: yesAGING MEDICINE, EarlyView.
Our study compared the discrimination and calibration of the Kwon Pneumonia Score, A2DS2 score, PANTHERIS score, AIS‐APS score, ISAN score, and PASS score in SAP identification; of these, the AIS‐APS score showed the best performance. ABSTRACT Objectives To compare the discrimination and calibration of six risk scoring systems in the assessment of ...
Linlin Wang   +8 more
wiley   +1 more source

Frontiers in Nondrug Treatment of Sarcopenia: A Review of Pathological Mechanisms and the Latest Treatment Strategies

open access: yesAGING MEDICINE, EarlyView.
This article mainly introduces the pathologic process of sarcopenia and the recent progress in diagnosis and treatment, especially the nondrug treatment. ABSTRACT Sarcopenia refers to the progressive decline and wasting of skeletal muscle function, typically linked to aging or as a secondary effect of various conditions, including systemic inflammation,
Qi‐Fei Kuang   +2 more
wiley   +1 more source

Comorbidities [PDF]

open access: yesDevelopmental Medicine & Child Neurology, 2003
openaire   +1 more source

Factors Associated With Anxiety Symptoms in Older Adults Attending an Outpatient Geriatric Service: A Cross‐Sectional Study

open access: yesAGING MEDICINE, EarlyView.
An analytical study was carried out by secondary analysis of a database of a study performed between 2010 and 2015 at the Naval Medical Center of Peru (CEMENA). the analysis revealed that depressive symptoms, polypharmacy, slow gait speed, education, and marital status were significant contributors to anxiety in this population.
Gianella Grajeda‐León   +7 more
wiley   +1 more source

Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia

open access: yesAmerican Journal of Hematology, Volume 98, Issue 1, Page 122-130, January 2023., 2023
Abstract Major options for second‐line therapy in adults with chronic immune thrombocytopenia (ITP) include splenectomy, rituximab, and thrombopoietin receptor agonists (TRAs). The American Society of Hematology guidelines recommend rituximab over splenectomy, TRAs over rituximab, and splenectomy or TRAs while noting a lack of evidence on the cost ...
George Goshua   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy